Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study.
Başaran Ö, Dogan V, Beton O, Tekinalp M, Aykan AC, Kalaycioğlu E, Bolat I, Taşar O, Şafak Ö, Kalcik M, Yaman M, İnci S, Altintaş B, Kalkan S, Kirma C, Biteker M; and Collaborators. Başaran Ö, et al. Among authors: beton o. Medicine (Baltimore). 2016 Aug;95(35):e4672. doi: 10.1097/MD.0000000000004672. Medicine (Baltimore). 2016. PMID: 27583892 Free PMC article.
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).
Başaran Ö, Beton O, Doğan V, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, Bolat İ, Taşar O, Şafak Ö, Kalçık M, Yaman M, Altun İ, Soylu MÖ, Kırma C, Biteker M; RAMSES Study. Başaran Ö, et al. Among authors: beton o. Anatol J Cardiol. 2016 Oct;16(10):734-741. doi: 10.14744/AnatolJCardiol.2016.6752. Anatol J Cardiol. 2016. PMID: 27723665 Free PMC article.
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
Başaran Ö, Dogan V, Beton O, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, Bolat I, Taşar O, Şafak Ö, Kalçık M, Yaman M, İnci S, Altıntaş B, Kalkan S, Kırma C, Biteker M; and Collaborators. Başaran Ö, et al. Among authors: beton o. J Thromb Thrombolysis. 2017 Feb;43(2):157-165. doi: 10.1007/s11239-016-1445-1. J Thromb Thrombolysis. 2017. PMID: 27848065 Clinical Trial.
Real-world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairment.
Mert KU, Mert GÖ, Başaran Ö, Beton O, Dogan V, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, Bolat I, Taşar O, Şafak Ö, Kalçık M, Yaman M, Kırma C, Biteker M; RAMSES investigators. Mert KU, et al. Among authors: beton o. Eur J Clin Invest. 2017 Jun;47(6):428-438. doi: 10.1111/eci.12758. Epub 2017 May 16. Eur J Clin Invest. 2017. PMID: 28407216 Clinical Trial.
Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR.
Emren SV, Şenöz O, Bilgin M, Beton O, Aslan A, Taşkin U, Açiksari G, Asarcikli LD, Çakir H, Bekar L, Bolat İ, Yayla Ç, Çelebi B, Dalgiç O, Çelik O, Şafak Ö, Akyel S, Güngör H, Düzel B, Zoghi M. Emren SV, et al. Among authors: beton o. Clin Appl Thromb Hemost. 2018 Apr;24(3):525-531. doi: 10.1177/1076029617693940. Epub 2017 Feb 19. Clin Appl Thromb Hemost. 2018. PMID: 28301907 Free PMC article.
55 results